S&P 500   3,122.03 (+0.05%)
DOW   28,036.22 (+0.11%)
QQQ   203.07 (+0.08%)
AAPL   267.10 (+0.50%)
FB   197.40 (+1.18%)
MSFT   150.34 (+0.25%)
GOOGL   1,319.84 (-1.03%)
AMZN   1,752.53 (+0.75%)
CGC   14.22 (-7.24%)
NVDA   212.28 (+3.96%)
MU   47.82 (+0.23%)
BABA   184.61 (-0.47%)
GE   11.44 (-0.69%)
TSLA   349.99 (-0.62%)
T   39.63 (+0.33%)
AMD   39.88 (+3.42%)
ACB   2.28 (-16.48%)
F   8.95 (+0.00%)
PRI   131.10 (+0.37%)
NFLX   302.57 (+2.56%)
BAC   32.96 (+0.09%)
GILD   64.29 (-1.20%)
DIS   147.65 (+2.06%)
S&P 500   3,122.03 (+0.05%)
DOW   28,036.22 (+0.11%)
QQQ   203.07 (+0.08%)
AAPL   267.10 (+0.50%)
FB   197.40 (+1.18%)
MSFT   150.34 (+0.25%)
GOOGL   1,319.84 (-1.03%)
AMZN   1,752.53 (+0.75%)
CGC   14.22 (-7.24%)
NVDA   212.28 (+3.96%)
MU   47.82 (+0.23%)
BABA   184.61 (-0.47%)
GE   11.44 (-0.69%)
TSLA   349.99 (-0.62%)
T   39.63 (+0.33%)
AMD   39.88 (+3.42%)
ACB   2.28 (-16.48%)
F   8.95 (+0.00%)
PRI   131.10 (+0.37%)
NFLX   302.57 (+2.56%)
BAC   32.96 (+0.09%)
GILD   64.29 (-1.20%)
DIS   147.65 (+2.06%)
S&P 500   3,122.03 (+0.05%)
DOW   28,036.22 (+0.11%)
QQQ   203.07 (+0.08%)
AAPL   267.10 (+0.50%)
FB   197.40 (+1.18%)
MSFT   150.34 (+0.25%)
GOOGL   1,319.84 (-1.03%)
AMZN   1,752.53 (+0.75%)
CGC   14.22 (-7.24%)
NVDA   212.28 (+3.96%)
MU   47.82 (+0.23%)
BABA   184.61 (-0.47%)
GE   11.44 (-0.69%)
TSLA   349.99 (-0.62%)
T   39.63 (+0.33%)
AMD   39.88 (+3.42%)
ACB   2.28 (-16.48%)
F   8.95 (+0.00%)
PRI   131.10 (+0.37%)
NFLX   302.57 (+2.56%)
BAC   32.96 (+0.09%)
GILD   64.29 (-1.20%)
DIS   147.65 (+2.06%)
S&P 500   3,122.03 (+0.05%)
DOW   28,036.22 (+0.11%)
QQQ   203.07 (+0.08%)
AAPL   267.10 (+0.50%)
FB   197.40 (+1.18%)
MSFT   150.34 (+0.25%)
GOOGL   1,319.84 (-1.03%)
AMZN   1,752.53 (+0.75%)
CGC   14.22 (-7.24%)
NVDA   212.28 (+3.96%)
MU   47.82 (+0.23%)
BABA   184.61 (-0.47%)
GE   11.44 (-0.69%)
TSLA   349.99 (-0.62%)
T   39.63 (+0.33%)
AMD   39.88 (+3.42%)
ACB   2.28 (-16.48%)
F   8.95 (+0.00%)
PRI   131.10 (+0.37%)
NFLX   302.57 (+2.56%)
BAC   32.96 (+0.09%)
GILD   64.29 (-1.20%)
DIS   147.65 (+2.06%)
Log in

CryoPort Stock Price, Forecast & Analysis (NASDAQ:CYRX)

$15.27
-0.29 (-1.86 %)
(As of 11/18/2019 04:00 PM ET)
Today's Range
$15.10
Now: $15.27
$15.61
50-Day Range
$13.61
MA: $14.65
$16.24
52-Week Range
$8.28
Now: $15.27
$25.02
Volume368,400 shs
Average Volume380,838 shs
Market Capitalization$547.34 million
P/E RatioN/A
Dividend YieldN/A
Beta0.77
CryoPort, Inc engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. Read More…

Industry, Sector and Symbol

Industry Freight transportation arrangement
Sub-IndustryN/A
SectorTransportation
Current SymbolNASDAQ:CYRX
CUSIPN/A
Phone949-470-2300

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$19.63 million
Book Value$3.08 per share

Profitability

Net Income$-9,560,000.00

Miscellaneous

EmployeesN/A
Market Cap$547.34 million
Next Earnings Date3/5/2020 (Estimated)
OptionableOptionable

Receive CYRX News and Ratings via Email

Sign-up to receive the latest news and ratings for CYRX and its competitors with MarketBeat's FREE daily newsletter.


CryoPort (NASDAQ:CYRX) Frequently Asked Questions

What is CryoPort's stock symbol?

CryoPort trades on the NASDAQ under the ticker symbol "CYRX."

How were CryoPort's earnings last quarter?

CryoPort Inc (NASDAQ:CYRX) announced its quarterly earnings data on Thursday, November, 7th. The consumer goods maker reported ($0.05) EPS for the quarter, beating analysts' consensus estimates of ($0.07) by $0.02. The consumer goods maker earned $9.58 million during the quarter, compared to the consensus estimate of $9.49 million. CryoPort had a negative return on equity of 26.50% and a negative net margin of 64.63%. The company's quarterly revenue was up 81.1% compared to the same quarter last year. During the same quarter in the prior year, the firm earned ($0.07) EPS. View CryoPort's Earnings History.

When is CryoPort's next earnings date?

CryoPort is scheduled to release their next quarterly earnings announcement on Thursday, March 5th 2020. View Earnings Estimates for CryoPort.

What price target have analysts set for CYRX?

4 brokers have issued twelve-month price targets for CryoPort's shares. Their forecasts range from $22.00 to $26.00. On average, they expect CryoPort's share price to reach $24.00 in the next twelve months. This suggests a possible upside of 57.2% from the stock's current price. View Analyst Price Targets for CryoPort.

What is the consensus analysts' recommendation for CryoPort?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CryoPort in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CryoPort.

Has CryoPort been receiving favorable news coverage?

News headlines about CYRX stock have been trending neutral this week, InfoTrie Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. CryoPort earned a media sentiment score of 0.3 on InfoTrie's scale. They also assigned news headlines about the consumer goods maker a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for CryoPort.

Are investors shorting CryoPort?

CryoPort saw a drop in short interest in the month of October. As of October 15th, there was short interest totalling 6,220,000 shares, a drop of 13.6% from the September 15th total of 7,200,000 shares. Based on an average trading volume of 660,200 shares, the days-to-cover ratio is currently 9.4 days. Currently, 17.7% of the shares of the stock are short sold. View CryoPort's Current Options Chain.

Who are some of CryoPort's key competitors?

What other stocks do shareholders of CryoPort own?

Who are CryoPort's key executives?

CryoPort's management team includes the folowing people:
  • Jerrell W. Shelton, Chairman, President & Chief Executive Officer
  • Phil Wilson, SVP-Global Operations & Supply Chain
  • Robert S. Stefanovich, Chief Financial Officer, Secretary & Treasurer
  • Bret Bollinger, Chief Technology Officer
  • Mark W. Sawicki, Chief Commercial Officer

Who are CryoPort's major shareholders?

CryoPort's stock is owned by a number of of institutional and retail investors. Top institutional investors include TimesSquare Capital Management LLC (3.78%), Columbus Circle Investors (0.99%), Creative Planning (0.97%), Taylor Wealth Management Partners (0.83%), SG Capital Management LLC (0.70%) and Handelsbanken Fonder AB (0.51%). Company insiders that own CryoPort stock include Jerrell Shelton and Richard J Berman. View Institutional Ownership Trends for CryoPort.

Which major investors are selling CryoPort stock?

CYRX stock was sold by a variety of institutional investors in the last quarter, including Creative Planning, Perkins Capital Management Inc., Taylor Frigon Capital Management LLC, Essex Investment Management Co. LLC, D.A. Davidson & CO., Rice Hall James & Associates LLC, Taylor Wealth Management Partners and Conestoga Capital Advisors LLC. View Insider Buying and Selling for CryoPort.

Which major investors are buying CryoPort stock?

CYRX stock was acquired by a variety of institutional investors in the last quarter, including TimesSquare Capital Management LLC, Columbus Circle Investors, SG Capital Management LLC, SG Americas Securities LLC, California Public Employees Retirement System, Handelsbanken Fonder AB, Cadence Capital Management LLC and Handelsinvest Investeringsforvaltning. View Insider Buying and Selling for CryoPort.

How do I buy shares of CryoPort?

Shares of CYRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is CryoPort's stock price today?

One share of CYRX stock can currently be purchased for approximately $15.27.

How big of a company is CryoPort?

CryoPort has a market capitalization of $547.34 million and generates $19.63 million in revenue each year. The consumer goods maker earns $-9,560,000.00 in net income (profit) each year or ($0.31) on an earnings per share basis. View Additional Information About CryoPort.

What is CryoPort's official website?

The official website for CryoPort is http://www.cryoport.com/.

How can I contact CryoPort?

CryoPort's mailing address is 17305 DAIMLER STREET, IRVINE CA, 92614. The consumer goods maker can be reached via phone at 949-470-2300 or via email at [email protected]


MarketBeat Community Rating for CryoPort (NASDAQ CYRX)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  169 (Vote Outperform)
Underperform Votes:  143 (Vote Underperform)
Total Votes:  312
MarketBeat's community ratings are surveys of what our community members think about CryoPort and other stocks. Vote "Outperform" if you believe CYRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CYRX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel